Anixa Biosciences, Inc. (ANIX)
NASDAQ·Healthcare·Biotechnology
$3.04
+2.36%
Mkt Cap $99.47M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | — | — | — | -$0.09 | -$0.08 | +11.11% | — | — |
| Q1 2026 Jan 12, 2026 | — | — | — | -$0.09 | -$0.09 | -2.31% | — | — |
| Q3 2025 Sep 10, 2025 | — | — | — | -$0.10 | -$0.07 | +30.00% | — | — |
| Q2 2025 May 28, 2025 | — | — | — | -$0.10 | -$0.09 | +10.00% | — | — |
| Q1 2025 Mar 11, 2025 | — | — | — | -$0.10 | -$0.10 | +0.00% | — | — |
| Q1 2025 Jan 10, 2025 | — | — | — | -$0.11 | -$0.09 | +18.18% | — | — |
| Q3 2024 Sep 6, 2024 | — | — | — | -$0.11 | -$0.10 | +9.09% | — | — |
| Q2 2024 Jun 4, 2024 | — | — | — | -$0.11 | -$0.10 | +9.09% | — | — |
| Q1 2024 Mar 12, 2024 | — | — | — | -$0.09 | -$0.10 | -11.11% | — | — |
| Q1 2024 Jan 16, 2024 | — | $156.00K | — | -$0.09 | -$0.09 | +0.00% | — | — |
| Q3 2023 Sep 6, 2023 | — | — | — | -$0.09 | -$0.08 | +11.11% | — | — |
| Q2 2023 Jun 14, 2023 | — | $210.00K | — | -$0.11 | -$0.07 | +36.36% | — | — |
| Q1 2023 Mar 16, 2023 | — | — | — | -$0.16 | -$0.08 | +50.00% | — | — |
| Q1 2023 Jan 4, 2023 | — | $2.47B | — | -$0.13 | -$0.12 | +7.69% | — | — |
| Q3 2022 Sep 9, 2022 | — | — | — | -$0.13 | -$0.09 | +30.77% | — | — |
| Q2 2022 Jun 10, 2022 | — | — | — | -$0.13 | -$0.12 | +7.69% | — | — |
| Q1 2022 Mar 11, 2022 | — | — | — | -$0.13 | -$0.13 | +0.00% | — | — |
| Q1 2022 Jan 4, 2022 | — | $3.61M | — | — | -$0.13 | — | — | — |
| Q3 2021 Sep 1, 2021 | — | — | — | -$0.08 | -$0.14 | -75.00% | — | — |
| Q2 2021 Jun 10, 2021 | — | — | — | -$0.10 | -$0.08 | +20.00% | — | — |